Maryland House Bill 1109

---

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on February 5 2025 - 25% progression
Action: 2025-02-10 - Hearing 3/05 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Hearing: Mar 5 @ 1:00 pm House Health and Government Operations Hearing
Text: Latest bill text (Introduced) [PDF]

Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product unless the purchaser provides to the retailer certain proof; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine product or a xylazine product to maintain certain records; etc.

Public Health - Medetomidine and Xylazine Consumer Protection Act

Del. Jesse Pippy [R]

Date	Chamber	Action
2025-02-10	House	Hearing 3/05 at 1:00 p.m.
2025-02-05	House	First Reading Health and Government Operations

SB875 (Crossfiled) 2025-02-06 - Hearing 3/06 at 1:00 p.m.

Chapter	Article	Section	Citation Type	Statute Text
Health - General	21-2F	01	(n/a)	See Bill Text
Health - General	21-2F	2	(n/a)	See Bill Text
Health - General	21-2F	3	(n/a)	See Bill Text
Health - General	8	6A-01	(n/a)	See Bill Text

Type	Source
Summary	https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1109?ys=2025RS
Text	https://mgaleg.maryland.gov/2025RS/bills/hb/hb1109f.pdf